Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Rhythm Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Price |
Fee Rate |
Amount of Registration Fee(1) | |||||||||
|
Fees to Be Paid |
Equity | Common stock, par value $0.001 per share | 457(o) |
$150,000,182.83 |
$150,000,182.83 |
0.00014760 |
$22,140.03 | |||||||||
|
Fees Previously Paid |
Equity | Common stock, par value $0.001 per share | 457(o) | $49,999,817.17 | $49,999,817.17 | 0.00010910 | $5,454.98(1) | |||||||||
| Total Offering Amounts | $200,000,000 | $27,595.01 | ||||||||||||||
| Total Fees Previously Paid | $5,454.98 | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $22,140.03 | |||||||||||||||
| (1) On March 2, 2023, the registrant registered pursuant to the Registration Statement and a prospectus supplement, dated March 2, 2023 (the “Prior Prospectus”), $100,000,000 of shares of its common stock and paid a filing fee of $9,270. As of the date hereof, the registrant has offered and sold $50,000,182.83 pursuant to the Prior Prospectus. The shares of common stock registered pursuant to the Registration Statement and the prospectus supplement dated as of the date hereof (the “Prospectus”) include $49,999,817.17 of unsold shares of common stock previously registered pursuant to the Prior Prospectus. The Prospectus amends and replaces the Prior Prospectus in its entirety and the registrant will not make any offers and sales pursuant to the Prior Prospectus after the Prospectus is filed with the Securities and Exchange Commission. |